Research Article
PTPRT Could Be a Treatment Predictive and Prognostic Biomarker for Breast Cancer
Table 1
Multivariable Cox proportional hazard model for PTPRT in breast cancer.
| | Coef | HR | 95%CI_lower | 95%CI_upper | value |
| Age | 0.034 | 1.034 | 1.019 | 1.05 | <0.0001 | Gender: male | 0.154 | 1.167 | 0.159 | 8.561 | 0.879 | Race: Black | -0.4 | 0.67 | 0.196 | 2.297 | 0.524 | Race: White | -0.58 | 0.56 | 0.173 | 1.812 | 0.333 | Stage 2 | 0.479 | 1.615 | 0.848 | 3.075 | 0.145 | Stage 3 | 1.307 | 3.693 | 1.903 | 7.167 | <0.0001 | Stage 4 | 2.58 | 13.201 | 5.845 | 29.817 | <0.0001 | Purity | 0.264 | 1.302 | 0.448 | 3.788 | 0.628 | B_cell | -1.393 | 0.248 | 0.002 | 28.446 | 0.565 | CD8_Tcell | -1.735 | 0.176 | 0.012 | 2.571 | 0.204 | CD4_Tcell | 1.062 | 2.891 | 0.053 | 156.739 | 0.602 | Macrophage | 3.336 | 28.094 | 1.591 | 496.112 | 0.023 | Neutrophil | 1.629 | 5.1 | 0.018 | 1441.713 | 0.572 | Dendritic | -0.735 | 0.48 | 0.055 | 4.2 | 0.507 | PTPRT | -0.092 | 0.912 | 0.86 | 0.968 | 0.002 |
|
|